Jihua Group(SH:601718) Zheng Quan Shi Bao Wang·2025-06-30 10:21Group 1: Market Performance - Jihua Group leads with a closing limit order volume of 896,400 hands, followed by Lianjian Optoelectronics with 222,900 hands [2] - 17 stocks have limit order funds exceeding 100 million yuan, with Jihua Group at the top with 351 million yuan [2] - Jihua Group's cumulative increase in June is 44.12% [2] Group 2: Brain-Computer Interface (BCI) Industry - The BCI technology is expected to drive a technological transformation in specific medical and consumer scenarios, with a projected global market growth of approximately 10 billion USD over the next decade [3] - The Chinese market is accelerating its growth, with the comprehensive industry scale expected to exceed 100 billion yuan [3] - Jihua Group has not yet engaged in BCI business, which is a project of its controlling shareholder, Xinxing Jihua Group [3] Group 3: Key Players in BCI - Xiangyu Medical focuses on non-invasive BCI technology for rehabilitation, with plans to explore invasive or semi-invasive fields [5] - Innovation Medical has a stake in Boli Brain-Computer (Hangzhou) Technology Co., which focuses on BCI technology and high-end medical devices [5] - Rongtai Health has established a strategic partnership with Shanghai Aoyi Information Technology Co. to develop a "Brain-Machine Interaction Joint Laboratory" [6] Group 4: Military Electronics Sector - Companies like *ST Chengchang and Sichuang Electronics are involved in military electronics, providing solutions for phased array radar and other applications [4] - Guorui Technology's radar products cater to national strategic needs and public welfare sectors [4]